Moderna Cancer Treatment Shows Promise in Clinical Trial

Why it matters locally: The development of a new cancer treatment holds potential implications for healthcare providers and patients across California, offering new avenues for personalized medicine.

---

Moderna's shares increased after the company announced positive results for its experimental mRNA-based cancer treatment. The therapy, called intismeran, is under development in collaboration with Merck. Researchers designed intismeran to be customized for individual patients. It targets specific mutations found within each patient's tumor.